2022
DOI: 10.1016/j.bioadv.2022.213021
|View full text |Cite
|
Sign up to set email alerts
|

Tailoring nanoparticles design for enhanced heating efficiency and improved magneto-chemo therapy for glioblastoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

4
1

Authors

Journals

citations
Cited by 10 publications
(11 citation statements)
references
References 71 publications
0
10
0
1
Order By: Relevance
“…This significant increase in temperature can be attributed to the higher anisotropy energy exhibited by the cube-like nanoparticles. 17 Anisotropic iron oxide-based nanomaterials, including nanocubes, core–shell nanostructures, and multicore MNPs, have been previously recognized for their exceptional magnetic heating capabilities, displaying specific loss powers significantly higher than those observed with conventional iron oxide nanoparticles utilized for MHCT.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…This significant increase in temperature can be attributed to the higher anisotropy energy exhibited by the cube-like nanoparticles. 17 Anisotropic iron oxide-based nanomaterials, including nanocubes, core–shell nanostructures, and multicore MNPs, have been previously recognized for their exceptional magnetic heating capabilities, displaying specific loss powers significantly higher than those observed with conventional iron oxide nanoparticles utilized for MHCT.…”
Section: Resultsmentioning
confidence: 99%
“…15 On the other hand, magnetic hyperthermia-based cancer therapy (MHCT) relies on the ability of magnetic nanoparticles (MNPs) to induce heat in response to an external alternating current magnetic field (AMF). 16,17 The oscillation of magnetic moments in MNPs generates a localized temperature rise, selectively killing heat-sensitive tumor cells with minimal adverse effects on healthy cells. 18,19 However, the use of MNPs in cancer therapeutics presents various challenges.…”
Section: Deepika Sharmamentioning
confidence: 99%
See 2 more Smart Citations
“…The biocompatibility of the complexes was investigated on a normal murine fibroblast cell line (L929), while the in vitro cytotoxicity of the compounds was evaluated on the human pancreatic cancer cell line MIA-PaCa-2 by the conventional MTT [3-(4,5-dimethylthiazol-2)-2,5diphenyl tetrazolium bromide] assay. 37 Briefly, 1 × 10 4 cells/mL were seeded in a flat-bottomed 96-well culture plate and incubated for 24 h at 37 °C and 5% CO 2 . A 1 mg/mL stock solution of compounds was prepared in DMSO.…”
Section: Biocompatibility and Anticancer Activity Of Complexesmentioning
confidence: 99%